(0.34%) 5 117.23 points
(0.41%) 38 396 points
(0.46%) 16 001 points
(-1.61%) $82.50
(4.73%) $2.01
(0.26%) $2 353.30
(0.20%) $27.59
(4.19%) $960.75
(-0.22%) $0.933
(-0.36%) $10.98
(-0.55%) $0.796
(1.69%) $93.43
0.00% $ 36.99
Live Chart Being Loaded With Signals
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide...
Stats | |
---|---|
Tagesvolumen | 1.02M |
Durchschnittsvolumen | 650 237 |
Marktkapitalisierung | 0.00 |
EPS | $0 ( 2021-08-02 ) |
Last Dividend | $0.100 ( 2021-06-16 ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.188 (0.51%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-07-14 | Ogunro Edward A | Sell | 10 760 | Common Stock |
2021-07-14 | Ogunro Edward A | Sell | 50 133 | Common Stock |
2021-07-14 | Mcnamara Kevin M | Sell | 24 443 | Common Stock |
2021-07-14 | Mcnamara Kevin M | Sell | 75 925 | Common Stock |
2021-07-14 | Erickson Thomas W | Sell | 79 204 | Common Stock |
INSIDER POWER |
---|
0.00 |
Last 100 transactions |
Buy: 1 457 367 | Sell: 3 933 642 |
Volumen Korrelation
Luminex Corporation Korrelation
10 Am meisten positiv korreliert | |
---|---|
DSPG | 0.935 |
CCRC | 0.923 |
TVTY | 0.893 |
STAY | 0.893 |
IQ | 0.89 |
AUGX | 0.887 |
PUCK | 0.882 |
ACAH | 0.882 |
SKYX | 0.875 |
CROX | 0.875 |
10 Am meisten negativ korreliert | |
---|---|
ODT | -0.927 |
TCDA | -0.921 |
XPDI | -0.911 |
EYEG | -0.91 |
ENPH | -0.901 |
GRAY | -0.895 |
LHDX | -0.89 |
LGHL | -0.879 |
HECCU | -0.879 |
MTEX | -0.877 |
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Luminex Corporation Korrelation - Währung/Rohstoff
Luminex Corporation Finanzdaten
Annual | 2020 |
Umsatz: | $417.40M |
Bruttogewinn: | $247.85M (59.38 %) |
EPS: | $0.336 |
FY | 2020 |
Umsatz: | $417.40M |
Bruttogewinn: | $247.85M (59.38 %) |
EPS: | $0.336 |
FY | 2019 |
Umsatz: | $334.64M |
Bruttogewinn: | $182.74M (54.61 %) |
EPS: | $-0.0900 |
FY | 2018 |
Umsatz: | $315.82M |
Bruttogewinn: | $195.49M (61.90 %) |
EPS: | $0.420 |
Financial Reports:
No articles found.
Luminex Corporation Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0600 | 2017-03-22 |
Last Dividend | $0.100 | 2021-06-16 |
Next Dividend | $0 | N/A |
Payout Date | 2021-07-08 | |
Next Payout Date | N/A | |
# dividends | 18 | -- |
Total Paid Out | $1.350 | -- |
Avg. Dividend % Per Year | 0.22% | -- |
Score | 4.31 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 3.83 | |
Div. Directional Score | 8.48 | -- |
Year | Amount | Yield |
---|---|---|
2017 | $0.240 | 1.18% |
2018 | $0.240 | 1.18% |
2019 | $0.300 | 1.32% |
2020 | $0.370 | 1.61% |
2021 | $0.200 | 0.82% |
2022 | $0 | 0.00% |
2023 | $0 | 0.00% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0363 | 1.500 | 9.27 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0197 | 1.200 | 9.34 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0309 | 1.500 | -0.768 | -1.152 | [0.1 - 1] |
payoutRatioTTM | 1.087 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 5.82 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 4.30 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 3.54 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.271 | -1.500 | 5.48 | -8.21 | [0 - 0.6] |
interestCoverageTTM | 3.56 | 1.000 | 9.79 | 9.79 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.090 | 2.00 | 9.64 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.699 | 2.00 | 9.65 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.404 | -1.500 | 8.38 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.594 | 1.000 | 3.44 | 3.44 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.102 | 1.000 | 9.97 | 9.97 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.239 | 1.000 | 9.78 | 9.78 | [0.2 - 2] |
assetTurnoverTTM | 0.542 | 0.800 | 9.72 | 7.78 | [0.5 - 2] |
Total Score | 13.13 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 111.73 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0309 | 2.50 | -0.494 | -1.152 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.699 | 2.00 | 9.77 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.090 | 2.00 | 9.64 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.087 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | -17.50 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.120 | 1.000 | 9.51 | 0 | [0.1 - 0.5] |
Total Score | 3.83 |
Luminex Corporation
Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries worldwide. Its products include Luminex 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; MAGPIX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids; ARIES system, a sample to answer real-time PCR platform; ARIES M1 system, a single-module version of the ARIES System; VERIGENE system, a semi-automated, multiplex, molecular analysis system for the clinical diagnostics market; FlowSight Imaging Flow cytometer; ImageStream System; CellStream Flow Cytometer; Guava easyCyte line; and Muse Cell Analyzer. The company also provides MicroPlex, MagPlex, xTAG, SeroMAP, and calibration and control microspheres; xPONENT, a software suite to simplify laboratory workflow and enhance productivity; SYNCT data management software solutions; TDAS, an analysis program designed for development and optimization of nucleic acid assays; IDEAS, an image analysis software; and xTAG assays and products to identify the causative agent for respiratory and gastrointestinal infections, as well as IVD kits for cystic fibrosis genotyping and pharmacogenetic assays used to profile genetic mutations related to drug metabolism. In addition, it offers MultiCode assays and products comprising HSV 1&2 assays, and other products to detect infectious agents in clinical samples; ARIES cassettes that are self-contained assay consumables, such as ARIES HSV 1&2 assays, ARIES FLU A/B and RSV assays, ARIES group A strep assays, ARIES bordetella assays, ARIES GBS assay, and ARIES C. difficile assays; and VERIGENE test cartridges. The company serves pharmaceutical companies, clinical laboratories, and research and medical institutions. Luminex Corporation was founded in 1995 and is based in Austin, Texas.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.